StonvexLoading…
StonvexStonvexStonvexCore line items from AENT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $880.89M | $622.68M | $253.97M | $1.06B |
Operating Income | $31.14M | $27.83M | $10.55M | $30.14M |
Net Income | $16.58M | $9.39M | $4.88M | $15.08M |
EPS (Diluted) | $0.32 | $0.28 | $0.10 | $0.30 |
Total Assets | $387.10M | $434.06M | $382.99M | $361.23M |
Total Liabilities | $267.15M | $316.48M | $274.86M | $258.01M |
Cash & Equivalents | $1.24M | $1.38M | $3.22M | $1.24M |
Free Cash Flow OCF − CapEx | $6.36M | $-14.53M | $2.38M | $26.75M |
Shares Outstanding | 50.97M | 50.96M | 50.96M | 50.96M |